Adverse Reactions to Intravenous Immunoglobulins - Our Experience
Authors:
Open Access
- 17 December 2018
- journal article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 6 (12) , 2359-2362
Abstract
BACKGROUND: Adverse reactions to intravenous immunoglobulins (IVIG) are divided by organ system involved, or by timing of onset–immediate which occur during infusion usually rate-related, true IgE-mediated anaphylaxis and delayed reaction which occur hours to days after the infusion. AIM: To describe the adverse events of patients given IVIG infusions. METHODS: Total number of patients receiving IVIG was 41 with 25 males (60.97%) and 16 females (39.02%), age 2 months-35 years. A total number of infusions was 1350. RESULTS: Total number of adverse reactions 15, 14 patients with immediate-type and 1 with delayed type. Total percentage of adverse reactions in a given sample was 1.1% of all IVIG infusions. Fever was the most common immediate type of reaction occurring in 11 patients (78.57%) followed by acrocyanosis 10 patients (71.42%), skin rash 9 patients (64.28%) and headache 8 patients (57.14). Delayed-type of reactions (like fever, headache and vomiting) was present in one patient. Majority of the adverse effects occurred at the infusion rate higher than 1, 5 ml/kg/hour, which is still within recommended speed. CONCLUSION: About 1.1% of IVG infusions where with adverse events. Most common manifestations where: fever, acrocyanosis, skin rash and headache, which occurred 1-6 hours from the beginning of the infusion. The occurrence of adverse reactions to IVIG was related to the infusion rates in a fashion that faster infusion rate gives more reactions. Adverse reactions were managed by reduction of the infusion rate and administration of medications such as paracetamol, antihistamines and steroids.Keywords
This publication has 8 references indexed in Scilit:
- Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience.2017
- Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusionsInternational Immunopharmacology, 2014
- [Adverse effects with ambulatory intravenous immunoglobulin administration in adult patients with common variable immunodeficiency].2014
- Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective studyAsia Pacific Allergy, 2013
- The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disordersJournal of Allergy and Clinical Immunology, 2011
- A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusionsArchives of Disease in Childhood, 2006
- Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literatureAnnals of Hematology, 2004
- Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacyNeurology, 2002